Ron Tavlin allegedly informed a friend about Medtronic’s impending acquisition announcement of Mazor Robotics in 2018.

Medtronic’s rollout of their Hugo robotics assisted surgical robot will be delayed due to supply-chain issues.

The CE mark covers urologic and gynecologic procedures, which make up approximately half of all robotic procedures performed today, according to the company.

The procedure marks the beginning of the Hugo system patient registry, which will collect clinical data as Medtronic seeks regulatory submissions.

In 2020, autonomous vehicles left other technology applications in the dust. Other areas of robotics receiving funding or merger and acquisition activity included supply chain automation, surgical robots, and quadrupeds.

In September 2020, healthcare robotics, drones for inspection, and industrial automation received funding, but transactions slowed for autonomous vehicle developers.

Geoff Martha, the new CEO of Medtronic, this week outlined plans for the medical device maker to gain leadership in robot-assisted surgical systems and other healthcare technologies.

In July 2020, autonomous vehicles, industrial automation, and surgical robots continued to receive funding at steady levels in comparison with the same period last year.

Titan Medical, which last year delayed research and development for its Sport surgical robot, has resumed work with new financing and help from Medtronic.

Titan Medical, which has been trying to raise money, and Medtronic, which has been looking to expand its surgical robotics offerings, have signed development, licensing, and loan agreements.

Phoenix Children’s Hospital today announced it will be the first health system in the U.S. to receive and deploy the newly FDA-cleared Medtronic Stealth Autoguide platform to perform robotic neurosurgery on pediatric patients. The platform will be used with Medtronic’s StealthStation system at the Barrow Neurological Institute (BNI) at Phoenix Children’s, with procedures expected to…

Medtronic said today some of its Mazor X surgical robotic systems could detach and fall onto the OR table, potentially injuring a patient. The problem affects Mazor X systems with positioner Type II, the company said in an urgent field safety notice (PDF) issued in the U.K. It wasn’t immediately clear if the problem that causes…

The range of surgical procedures that robots can assist is widening, even as systems become more specialized.

Medtronic is taking advantage of its experience in medical device manufacturing and instrumentation in the development of its new modular robot-assisted surgical platform.

In July 2019, investments in robotics, autonomous vehicles, and drones increased, despite a decline in the number of transactions.

Medtronic, which has made no secret of its surgical robotics ambitions, partnered with visualization company Karl Storz SE & Co. as it works on its own robot-assisted surgery platform.

Orthopedic device companies have been actively developing products for surgical robotics, several through acquisitions.

Stryker’s success with its Mako robot-assisted surgery platform has other orthopedic device companies hastening to enter the space. The big question is whether long-term outcomes will justify the expensive technology.

Medtronic is betting robot-assisted surgery could be a game changer when it comes to spine surgeries. The company late last year closed on its $1.7 billion purchase of Mazor Robotics and its robot-assisted surgery platform for the spine. A month later, Medtronic launched its Mazor X Stealth robotic-assisted spinal surgical platform in the U.S. The…

Medtronic has launched its Mazor X Stealth robotic-assisted spinal surgical platform in the U.S., touting its recent use in its first commercial procedures. The first uses of the system took place at Louisville, Ky.’s Norton Healthcare and Reston, Va.’s Reston Hospital Center, the Fridley, Minn.-based medtech giant said. “The marriage of robotics and navigation represents the…

Medtronic has closed the $1.7 billion acquisition of Mazor Robotics and its robot-assisted surgery platform. Medtronic capped the buyout with the announcement that its first jointly produced product won an FDA nod. Last month Caesarea, Israel-based Mazor said its shareholders voted to approve the $58.50-per-ADR-share deal with the world’s largest medical device maker, which has…

Medtronic has owned since 2016 a $300 million stake (about 11%) in Mazor, which is widely regarded as a leader in robot-assisted spine surgery. By 2022, the global spinal surgical robotics market is expected to reach $2.77 billion. Mazor makes the Mazor X guidance system and the Renaissance robot-assisted spine surgery platform. Medtronic became the…